Literature DB >> 21749039

Proinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus.

Ying-Chi Lin1, Michele J Anderson, Petra L Kohler, Kristi L Strandberg, Michael E Olson, Alexander R Horswill, Patrick M Schlievert, Marnie L Peterson.   

Abstract

Pulsed-field gel electrophoresis (PFGE) clonal type USA200 is the most widely disseminated Staphylococcus aureus colonizer of the nose and is a major cause of toxic shock syndrome (TSS). Exoproteins derived from these organisms have been suggested to contribute to their colonization and causation of human diseases but have not been well-characterized. Two representative S. aureus USA200 isolates, MNPE (α-toxin positive) and CDC587 (α-toxin mutant), isolated from pulmonary post-influenza TSS and menstrual vaginal TSS, respectively, were evaluated. Biochemical, immunobiological, and cell-based assays, including mass spectrometry, were used to identify key exoproteins derived from the strains that are responsible for proinflammatory and cytotoxic activity on human vaginal epithelial cells. Exoproteins associated with virulence were produced by both strains, and cytolysins (α-toxin and γ-toxin), superantigens, and proteases were identified as the major exoproteins, which caused epithelial cell inflammation and cytotoxicity. Exoprotein fractions from MNPE were more proinflammatory and cytotoxic than those from CDC587 due to high concentrations of α-toxin. CDC587 produced a small amount of α-toxin, despite the presence of a stop codon (TAG) at codon 113. Additional exotoxin identification studies of USA200 strain [S. aureus MN8 (α-toxin mutant)] confirmed that MN8 also produced low levels of α-toxin despite the same stop codon. The differences observed in virulence factor profiles of two USA200 strains provide insight into environmental factors that select for specific virulence factors. Cytolysins, superantigens, and proteases were identified as potential targets, where toxin neutralization may prevent or diminish epithelial damage associated with S. aureus.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21749039      PMCID: PMC3156861          DOI: 10.1021/bi200435n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  42 in total

1.  Efficacy of concurrent application of chlorhexidine gluconate and povidone iodine against six nosocomial pathogens.

Authors:  Michele J Anderson; Mary E Horn; Ying-Chi Lin; Patrick J Parks; Marnie L Peterson
Journal:  Am J Infect Control       Date:  2010-10-30       Impact factor: 2.918

Review 2.  Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa.

Authors:  Christopher A Squier; Mary J Mantz; Patrick M Schlievert; Catherine C Davis
Journal:  J Pharm Sci       Date:  2008-01       Impact factor: 3.534

3.  Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins.

Authors:  R N Fichorova; J G Rheinwald; D J Anderson
Journal:  Biol Reprod       Date:  1997-10       Impact factor: 4.285

4.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Authors:  Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-10       Impact factor: 11.205

5.  Toxin involvement in toxic shock syndrome.

Authors:  B A Crass; M S Bergdoll
Journal:  J Infect Dis       Date:  1986-05       Impact factor: 5.226

6.  Associations between Staphylococcus aureus Genotype, Infection, and In-Hospital Mortality: A Nested Case-Control Study.

Authors:  Heiman F L Wertheim; Willem B van Leeuwen; Susan Snijders; Margreet C Vos; Andreas Voss; Christina M J E Vandenbroucke-Grauls; Jan A J W Kluytmans; Henri A Verbrugh; Alex van Belkum
Journal:  J Infect Dis       Date:  2005-08-24       Impact factor: 5.226

Review 7.  Regulated translational bypass of stop codons in yeast.

Authors:  Tobias von der Haar; Mick F Tuite
Journal:  Trends Microbiol       Date:  2006-12-21       Impact factor: 17.079

Review 8.  The role of nasal carriage in Staphylococcus aureus infections.

Authors:  Heiman F L Wertheim; Damian C Melles; Margreet C Vos; Willem van Leeuwen; Alex van Belkum; Henri A Verbrugh; Jan L Nouwen
Journal:  Lancet Infect Dis       Date:  2005-12       Impact factor: 25.071

9.  Corneal virulence of Staphylococcus aureus in an experimental model of keratitis.

Authors:  Joseph J Dajcs; Brett A Thibodeaux; Dalia O Girgis; Richard J O'Callaghan
Journal:  DNA Cell Biol       Date:  2002 May-Jun       Impact factor: 3.311

Review 10.  Proteomics of Staphylococcus aureus--current state and future challenges.

Authors:  Michael Hecker; Susanne Engelmann; Stuart J Cordwell
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-04-05       Impact factor: 3.205

View more
  29 in total

1.  Superantigens of Staphylococcus aureus from patients with diabetic foot ulcers.

Authors:  Bao G Vu; Christopher S Stach; Wilmara Salgado-Pabón; Daniel J Diekema; Sue E Gardner; Patrick M Schlievert
Journal:  J Infect Dis       Date:  2014-06-20       Impact factor: 5.226

2.  Vaccination against Staphylococcus aureus pneumonia.

Authors:  Adam R Spaulding; Wilmara Salgado-Pabón; Joseph A Merriman; Christopher S Stach; Yinduo Ji; Aaron N Gillman; Marnie L Peterson; Patrick M Schlievert
Journal:  J Infect Dis       Date:  2013-12-19       Impact factor: 5.226

3.  Menaquinone analogs inhibit growth of bacterial pathogens.

Authors:  Patrick M Schlievert; Joseph A Merriman; Wilmara Salgado-Pabón; Elizabeth A Mueller; Adam R Spaulding; Bao G Vu; Olivia N Chuang-Smith; Petra L Kohler; John R Kirby
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

4.  Staphopains modulate Staphylococcus aureus biofilm integrity.

Authors:  Joe M Mootz; Cheryl L Malone; Lindsey N Shaw; Alexander R Horswill
Journal:  Infect Immun       Date:  2013-06-24       Impact factor: 3.441

5.  Mouse model of hematogenous implant-related Staphylococcus aureus biofilm infection reveals therapeutic targets.

Authors:  Yu Wang; Lily I Cheng; David R Helfer; Alyssa G Ashbaugh; Robert J Miller; Alexander J Tzomides; John M Thompson; Roger V Ortines; Andrew S Tsai; Haiyun Liu; Carly A Dillen; Nathan K Archer; Taylor S Cohen; Christine Tkaczyk; C Kendall Stover; Bret R Sellman; Lloyd S Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-12       Impact factor: 11.205

6.  Discovery and characterization of aryl isonitriles as a new class of compounds versus methicillin- and vancomycin-resistant Staphylococcus aureus.

Authors:  Dexter C Davis; Haroon Mohammad; Kwaku Kyei-Baffour; Waleed Younis; Cassidy Noel Creemer; Mohamed N Seleem; Mingji Dai
Journal:  Eur J Med Chem       Date:  2015-06-16       Impact factor: 6.514

Review 7.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

Review 8.  Models matter: the search for an effective Staphylococcus aureus vaccine.

Authors:  Wilmara Salgado-Pabón; Patrick M Schlievert
Journal:  Nat Rev Microbiol       Date:  2014-07-07       Impact factor: 60.633

9.  Development of an in vitro colonization model to investigate Staphylococcus aureus interactions with airway epithelia.

Authors:  Megan R Kiedrowski; Alexandra E Paharik; Laynez W Ackermann; Annie U Shelton; Sachinkumar B Singh; Timothy D Starner; Alexander R Horswill
Journal:  Cell Microbiol       Date:  2016-01-12       Impact factor: 3.715

Review 10.  Exploration of Modulated Genetic Circuits Governing Virulence Determinants in Staphylococcus aureus.

Authors:  Rekha Arya; S Adline Princy
Journal:  Indian J Microbiol       Date:  2015-10-22       Impact factor: 2.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.